Cipla stock rises nearly 2% after USFDA grants VAI status to Goa plant
Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying
Continue readingThe Number One Finance & Business Blog!
Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying
Continue readingIndian automotive giant Mahindra & Mahindra announced today its plans to unveil two new electric SUVs, the XEV 9e and
Continue readingNomura on L&T Buy, TP Rs 4100 Beats consensus; offers favorable risk-reward FY25 order inflow growth guidance looks achievable post
Continue readingG R Infraprojects Limited has secured an Engineering, Procurement and Construction (EPC) contract worth ₹1,885.63 crore for a section of
Continue readingThe shares of Nazara Technologies Limited were trading at ₹938.50 up by ₹2.60 or 0.28 per cent on the NSE
Continue readingThe November 5 US presidential elections, Federal Reserve interest rate decision, trading activity of foreign investors, and the upcoming quarterly
Continue readingThe combined market valuation of 6 of the top-10 most-valued firms surged ₹1,07,366.05 crore last week, with State Bank of
Continue readingForeign Portfolio Investors (FPIs) continued their aggressive selling spree last week, leading to record-breaking monthly gross outflows of approximately $13.5
Continue readingThanks to the robust collection through new fund offers and steady market rally, the average asset under management of the
Continue readingI have shares of Infibeam Avenues. My purchase price is ₹42. Should I continue to hold or exit with loss?
Continue reading